CELU (Celularity Inc. Class A Common Stock) Stock Analysis - Analyst Ratings

Celularity Inc. Class A Common Stock (CELU) is a publicly traded Healthcare sector company. As of May 21, 2026, CELU trades at $0.89 with a market cap of $23.11M and a P/E ratio of -0.31. CELU moved +4.21% today. Year to date, CELU is -34.51%; over the trailing twelve months it is -64.58%. Its 52-week range spans $0.71 to $5.22. Rallies surfaces CELU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate CELU?

The average price target is $0.00.

CELU Key Metrics

Key financial metrics for CELU
MetricValue
Price$0.89
Market Cap$23.11M
P/E Ratio-0.31
EPS$-2.64
Dividend Yield0.00%
52-Week High$5.22
52-Week Low$0.71
Volume1.20K
Avg Volume0
Revenue (TTM)$54.22M
Net Income$-57.89M
Gross Margin72.36%

CELU Analyst Consensus

CELU analyst coverage data. Average price target: $0.00.

Latest CELU News

Common questions about CELU

What do analysts rate CELU?
The average price target is $0.00.
Does Rallies show CELU price targets?
Yes. Rallies tracks CELU analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is CELU research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CELU. It does not provide personalized investment advice.
CELU

CELU